Search

everythinglearnresearchcommunity

for

Search:↓

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Betulinic acid can help treat hepatitis C by stopping virus replication.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Two patients with stubborn hair loss grew hair after PDRN injections.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Abatacept may help some people with alopecia areata regrow hair.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Provenge extends prostate cancer survival by about 4 months.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

A new patch can deliver stable antibodies over time for potential HIV treatment.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.